Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized Trial of Intra-Articular Injections of 20mg of Hyalgan for the Treatment of Knee Pain Due to Osteoarthritis (Three Injection Regimen for Efficacy and Duration - 20mg/2ml Dose) - Extension Study

NCT00830830 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00830830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00830830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized Trial of Intra-Articular Injections of 20mg of Hyalgan for the Treatment of Knee Pain Due to Osteoarthritis (Three Injection Regimen for Efficacy and Duration - 20mg/2ml Dose) - Extension Study
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2005
Completion date
October 31, 2006
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis